Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

NCT01259726 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
173
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire